Skip to main content
SpringerLink
Log in

Serial changes in the myocardial β-adrenergic signalling system in two models of non-insulin dependent diabetes mellitus

  • Published:
Molecular and Cellular Biochemistry Aims and scope Submit manuscript

Abstract

Since it was reported in 1991 by Schaffer et al. that myocardial contractile responsiveness was altered in NIDDM in the absence of alterations in the β-adrenergic receptor population, researchers have been seeking a post-receptor defect to account for this. The present study addresses this issue by comparing alterations occurring in the myocardial β-receptor signalling pathway in two different models of rat NIDDM, as well as the response of the pathway after stimulation with isoproterenol in the presence or absence of insulin. The characteristics of the β-receptor population, adenylyl cyclase activity and cAMP levels were determined at three different ages. The main results demonstrate that: (i) the two models of NIDDM myocardium differ biochemically; (ii) the β-adrenergic signalling system of the insulin deficient model was altered more than the hyperinsulinemic model and (iii) the observed exaggerated cAMP response of NIDDM hearts after stimulation with a β-adrenergic agonist is in contrast with lower responsivity.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Regan TJ, Lyons MM, Ahmed SS, Levinson GE, Oldewurtel HA, Ahmad MR, Haider: Evidence for cardiomyopathy in familial diabetes mellitus. J Clin Invest 60: 885–899, 1977

    Google Scholar 

  2. Zaninetti D, Greco-Perotto R, Assimacopoulos-Jeannet F, Jeanrenaud B: Effects of insulin on glucose transport and transporters in rat heart. Biochem J 250: 277–283, 1988

    Google Scholar 

  3. Gotzsche O: Myocardial cell dysfunction in diabetes mellitus. A review of clinical and experimental studies. Diabetes 35: 1158–1162, 1986

    Google Scholar 

  4. Ganguly PK, Dhalla KS, Innes IR, Beamish RE, Dhalla NS: Altered norepinephrine turnover and metabolism in diabetic cardiomyopathy. Circ Res 59: 684–693, 1986

    Google Scholar 

  5. Atkins FL, Dowell RT, Love S: β-Adrenergic receptors, adenylate cyclase activity and cardiac dysfunction in the diabetic rat. J Cardiovasc Pharmacol 7: 66–70, 1985

    Google Scholar 

  6. Williams RS, Schaible TF, Scheuer J, Kennedy R: Effects of experimental diabetes on adrenergic and cholinergic receptors of rat myocardium. Diabetes 32: 881–886, 1983

    Google Scholar 

  7. Heyliger CE, Pierce GN, Singal PK, Beamish RE, Dhalla NS: Cardiac alpha-and beta-adrenergic receptor alterations in diabetic cardiomyopathy. Basic Res Cardiol 77: 610–618, 1982

    Google Scholar 

  8. Gotzche O: The adrenergic b-receptor adenylate cyclase system in heart and lymphocytes from streptozotocin-diabetic rats. In vivo and in vitro evidence for a desensitized myocardial β-receptor. Diabetes 32: 1110–1116, 1983

    Google Scholar 

  9. Wichelhaus A, Russ M, Petersen S, Eckel J: G protein expression and adenylate cyclase regulation in ventricular cardiomyocytes from STZ-diabetic rats. Am J Physiol 267: H548–H555, 1994

    Google Scholar 

  10. Ingebretsen WR, Peralta C, Monsher M, Wagner LK, Ingebretsen CG: Diabetes alters the myocardial cAMP-protein kinase cascade system. Am J Physiol 240: H375–382, 1981

    Google Scholar 

  11. Miller TB Jr: Phosphorylase activation hypersensitivity in hearts of diabetic rats. Am J Physiol 246: E134–140, 1984

    Google Scholar 

  12. Schaffer SW, Allo S, Punna S, White T: Defective response to cAMP-dependent protein kinase in non-insulin-dependent diabetic heart. Am J Physiol 261: E396–376, 1991

    Google Scholar 

  13. Ozuari A, Ozturk Y, Yildizoglu-Ari N, Ozcelkay AT, Altan VM: The effects of glyburide and insulin on the cardiac performance in rats with non-insulin-dependent diabetes mellitus. Gen Pharmacol 24: 165–169, 1993

    Google Scholar 

  14. Banyasz T, Kalapos I, Kelemen SZ, Kovacs T: Changes in cardiac contractility in IDDM and NIDDM diabetic rats. Gen Physiol Biophys 15: 357–369, 1996

    Google Scholar 

  15. Collins S, Daniel KW, Tohlfs EM, Ramkumar V, Taylor IL, Gettys TW: Impaired expression and functional activity of the beta 3-and beta 1-adrenergic receptors in adipose tissue of congenitally obese (C57BL/6J ob/ob) mice. Mol Endocrinol 8: 518–527, 1994

    Google Scholar 

  16. Keely SL, Corbin JD, Park CR: Regulation of adenosine 3':5'-monophosphate-dependent protein kinase: Regulation of the heart enzyme by epinephrine, glucagon, insulin and 1-methyl-3-isobutylxanthine. J Biol Chem 250: 4832–4840, 1975

    Google Scholar 

  17. Narayanan N, Derby JA: Alterations in the properties of beta-adrenergic receptors of myocardial membranes in aging: impairments in agonist-receptor interactions and guanine nucleotide regulation accompany diminished catecholamine-responsiveness of adenylate cyclase. Mech Ageing Dev 19: 127–139, 1982

    Google Scholar 

  18. Scarpace PJ: Decreased beta-adrenergic responsiveness during senescence. Fed Proc 45: 51–54, 1986

    Google Scholar 

  19. Sakai M, Danziger RS, Xiao RP, Sprugeon HA, Lakatta EG: Contractile response of individual cardiac myocytes to norepinephrine declines with senescence. Am J Physiol 262: H184–189, 1992

    Google Scholar 

  20. Zaninetti D, Crettax M, Jeanrenaud B: Dysregulation of glucose transport in hearts of genetically obese (fa/fa) rats. Diabetologia 25: 525–529, 1983

    Google Scholar 

  21. Portha B, Blondel O, Serradas P, Mc Evoy R, Giroix M-H, Kergoat M, Bailbe D: The rat models of non-insulin dependent diabetes induces by neonatal streptozotocin. Diabetes Metab 15: 61–75, 1989

    Google Scholar 

  22. Strasser RH, Braun-Dullaeus R, Walendzik H, Marquetant R: α1-Receptor-independent activation of protein kinase C in acute myocardial ischaemia. Mechanisms for sensitization of the adenylyl cyclase system. Circ Res 70: 1304–1312, 1992

    Google Scholar 

  23. Lowry AO, Rosenbrough NF, Farr AL, Randall RJ: Protein with the folin phenol reagent. J Biol Chem 193: 265–275, 1951

    Google Scholar 

  24. Kaplan RS, Pedersen PL: Determination of microgram quantities of protein in the presence of milligram levels of lipid with Amido Black 10B. Analyt Biochem 150: 97–104, 1985

    Google Scholar 

  25. Strasser RH, Krimmer J, Braun-Dullaeus R, Marquetant R, Kübler W: Dual sensitization of the adrenergic system in early myocardial ischaemia: Independent regulation of the β-adrenergic receptors and the adenylyl cyclase. J Mol Cell Cardiol 22: 1405–1423, 1990

    Google Scholar 

  26. Salomon Y, Londos C, Rodbell MA: A highly sensitive adenylyl cyclase assay. Anal Biochem 58: 541–548, 1974

    Google Scholar 

  27. Jakobs KH, Saur W, Schultz G: Reduction of adenylyl cyclase activity in lysates of human platelets by the α-adrenergic component of epinephrine. J Cyclic Nucl Res 2: 381–392, 1976

    Google Scholar 

  28. Hsu KL, Chiang FT, Lo HM, Tsai CH, Tseng CD, Tweng YZ: Cardiac contractility in noninsulin dependent diabetes mellitus evaluated using the relation between endsystolic wall stress and velocity of circumferential fiber shortening. Jpn Heart J 38: 463–471, 1997

    Google Scholar 

  29. Yu ZW, Jansson PA, Posner BI, Smith U, Eriksson JW: Peroxovanadate and insulin action in adipocytes from NIDDM patients. Evidence against a primary defect in tyrosine phosphorylation. Diabetologia 40: 1197–1203, 1997, 1983

    Google Scholar 

  30. Ingebretsen CG, Haweln-Johnson C, Ingebretsen WR: Alloxaninduced diabetes reduces β-adrenergic receptor number without affecting adenylate cyclase in rat ventricular membranes. J Cardiovasc Pharmacol 5: 454–461, 1983

    Google Scholar 

  31. Ramanadham S, Tenner TE Jr: Alterations in the myocardial betaadrenoceptor system of streptozotocin-diabetic rats. Eur J Pharmacol 136: 377–389, 1987

    Google Scholar 

  32. Nishio Y, Kashiwagi A, Kida Y, Kodama M, Abe N, Saeki Y, Shigeta Y: Deficiency of cardiac beta-adrenergic receptor in streptozotocin-induced diabetic rats. Diabetes 37: 1181–1187, 1988

    Google Scholar 

  33. Kamata K, Satoh T, Tanaka H, Shigenobu K: Changes in electrophysiological and mechanical responses of the rat papillary muscle to alpha-and beta-agonist in streptozotocin-induced diabetes. Can J Physiol Pharmacol 75: 781–788, 1997

    Google Scholar 

  34. Smith CI, Pierce GN, Challa NS: Alterations in adenylate cyclase activity due to streptozotocin-induced diabetic cardiomyopathy. Life Sci 34: 1223–1230, 1984

    Google Scholar 

  35. Michel A, Cros GH, McNeill JH, Serrano JJ: Cardiac adenylate cyclase activity in streptozotocin-treated rats after 4 months of diabetes: Impairment of epinephrine and glucagon stimulation. Life Sci 37: 2067–2075, 1985

    Google Scholar 

  36. Gawler D, Milligan G, Houslay MD: Treatment of streptozotocindiabetic rats with metformin restores the ability of insulin to inhibit adenylate cyclase activity and demonstrates that insulin does not exert this action through the inhibitory guanine nucleotide regulatory protein Gi. Biochem Biophys Res Commun 115: 583–589, 1983

    Google Scholar 

  37. Panagia V, Michiel DF, Dhalla KS, Jijjar MS, Dhalla NS: Role of phosphatidylinositol in basal adenylate cyclase activity of rat heart sarcolemma. Biochim Biophys Acta 676: 395–400, 1981

    Google Scholar 

  38. Kennington AS, Hill CR, Craig J, Bogardus C, Raz I, Ortmeyer HK, Hansen BC, Romero G, Larner J: Low urinary chiro-inositol excretion in non-insulin-dependent diabetes mellitus. N Engl J Med 323: 373–378, 1990

    Google Scholar 

  39. Han X, Bonen A: Epinephrine translocates GLUT-4 but inhibits insulin-stimulated glucose transport in rat muscle. Am J Physiol 274: E700–707, 1998

    Google Scholar 

  40. Egan JJ, Greenberg AS, Chang MK, Londos C: Control of endogenous phosphorylation of the major cAMP-dependent protein kinase substrate in adipocytes by insulin and beta-adrenergic stimulation. J Biol Chem 265: 18769–18775, 1990

    Google Scholar 

  41. Muller G, Grey S, Jung C, Bandlow W: Insulin-like signaling in yeast: Modulation of protein phosphatase 2A, protein kinase A, cAMP-specific phosphodiesterase, and glycosyl-phosphatidylinositol-specific phospholipase C activities. Biochemistry 39: 1475–1488, 2000

    Google Scholar 

  42. Okubo M, Bogardus C, Lillioja S, Mott DM: Adenosine 3',5'-monophosphate-dependent protein kinase activity decreases in human muscle after insulin infusion. J Clin Endocrinol Metab 69: 798–803, 1989

    Google Scholar 

  43. Ortmeyer HK: Insulin decreases skeletal muscle cAMP-dependent protein kinase (PKA) activity in normal monkeys and increases PKA activity in insulin-resistant rhesus monkeys. J Basic Clin Physiol Pharmacol 8: 223–235, 1997

    Google Scholar 

  44. Kida Y, Nyomba BL, Bogardus C, Mott DM: Defective insulin response of cyclic adenosine monophosphate-dependent protein kinase in insulin-resistant humans. J Clin Invest 87: 673–679, 1991

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Medical Physiology and Biochemistry, Faculty of Medicine, University of Stellenbosch and MRC Programme for Experimental Biology, Tygerberg, Republic of South Africa E-mail

    Barbara Huisamen, Erna Marais, Sonia Genade & Amanda Lochner

Authors
  1. Barbara Huisamen
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Erna Marais
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Sonia Genade
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Amanda Lochner
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Barbara Huisamen.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Huisamen, B., Marais, E., Genade, S. et al. Serial changes in the myocardial β-adrenergic signalling system in two models of non-insulin dependent diabetes mellitus. Mol Cell Biochem 219, 73–82 (2001). https://doi.org/10.1023/A:1011014909231

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1011014909231

Search

Navigation